Trial Details

TERMINATED
Basic Information
Clinical ID c651
Identifier NCT00586807
Trial Title Metabolic Response to Infliximab in Pediatric Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Protein Metabolism|Energy Expenditure
Interventions OTHER: Stable amino acid isotopes
Participant Information
Sponsor Indiana University
City Indianapolis
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2025-06-05
Primary Completion Date 2025-09-08
Completion Date 2025-09-08